Shoichi Ito

Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial

Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki et al. · The Lancet Neurology · 2010 · 187 citations

Jasmitt Study, Clinical Injury, Neurological Disorder +10

“Cloud‐like enhancement” is a magnetic resonance imaging abnormality specific to neuromyelitis optica

Shoichi Ito, Masahiro Mori, Takahiro Makino et al. · Annals of Neurology · 2009 · 160 citations

Ophthalmology, Neurophysiology, Neuroanatomy +15

“Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis

Tadahiro Yonezu, Shoichi Ito, Masahiro Mori et al. · Multiple Sclerosis Journal · 2013 · 125 citations

Distinct molecular mechanisms of <i>HTRA1</i> mutants in manifesting heterozygotes with CARASIL

Hiroaki Nozaki, Taisuke Kato, Megumi Nihonmatsu et al. · Neurology · 2016 · 111 citations

Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks

Akiyuki Uzawa, Masahiro Mori, Setsu Sawai et al. · Clinica Chimica Acta · 2013 · 88 citations

Inflammation, Ganglion Cell, Neurobiology Of Disease +11